Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care Stock Forecast

Stock Price Forecast

The 16 analysts that cover Tandem Diabetes Care stock have a consensus rating of "Buy" and an average price target of $22, which forecasts a 6.54% increase in the stock price over the next year. The lowest target is $12 and the highest is $55.

Price Target: $22 (+6.54%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$22	$22	$55
Change	-41.89%	+6.54%	+6.54%	+166.34%

Analyst Ratings

The average analyst rating for Tandem Diabetes Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	2	2	2
Buy	4	3	4	4	3	3
Hold	6	10	10	11	11	11
Sell	0	0	0	0	0	0
Strong Sell	1	0	0	0	0	0
Total	13	15	16	17	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Wood Morgan Stanley	Morgan Stanley	Hold Maintains $17 → $23	Hold	Maintains	$17 → $23	+11.38%	Dec 2, 2025
Matt Miksic Barclays	Barclays	Buy Maintains $51 → $55	Buy	Maintains	$51 → $55	+166.34%	Nov 10, 2025
Patrick Wood Morgan Stanley	Morgan Stanley	Hold Maintains $13 → $17	Hold	Maintains	$13 → $17	-17.68%	Nov 10, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Reiterates $16 → $17	Hold	Reiterates	$16 → $17	-17.68%	Nov 10, 2025
Larry Biegelsen Wells Fargo	Wells Fargo	Hold Maintains $13 → $14	Hold	Maintains	$13 → $14	-32.20%	Nov 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.02B

Increased by 8.59%

from 940.20M

Revenue Next Year

1.13B

Increased by 10.19%

from 1.02B

EPS This Year

-1.88

from -1.47

EPS Next Year

-0.96

from -1.88

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	498.83M	702.80M	801.22M	747.72M	940.20M	1.02B	1.13B
Revenue Growth	37.68%	40.89%	14.00%	-6.68%	25.74%	8.59%	10.19%
EPS	-0.56	0.24	-1.47	-3.43	-1.47	-1.88	-0.96
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	27	27

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.1B	1.2B
Avg	1.0B	1.1B
Low	975.9M	1.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	12.4%	16.9%
Avg	8.6%	10.2%
Low	3.8%	2.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-1.58	-0.45
Avg	-1.88	-0.96
Low	-2.62	-2.34

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.